DR. MARLON B. KLEINMAN M.D.
Prescription History 1255343521
Internal Medicine - Hematology & Oncology in Morton Grove, IL
Medicare Part D Prescription History
Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for DR. MARLON B. KLEINMAN M.D., an active Hematology & Oncology specialist practicing in Morton Grove, IL. Our medical registry currently tracks 24 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 701 documented patient claims. Among these therapy options, the most frequently utilized medication is Eliquis, which accounts for 93 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.
| Medication | Prescriptions (2023)Rx (2023) | Avg Cost per FillCost / Fill | Vs. Other IL PrescribersVs. IL Avg |
|---|---|---|---|
| EliquisApixaban | 93 | $898.87 | ≈ Typical |
About Eliquis: Apixaban is used to prevent serious blood clots from forming due to a certain irregular heartbeat (atrial fibrillation) or after hip/knee replacement surgery. Show more ▾ With atrial fibrillation, part of the heart does not beat the way it should. This can lead to blood clots forming, which can travel to other parts of your body (such as the lungs or legs) or increase your risk for stroke. In the United States, apixaban is also approved to treat certain types of blood clots (deep vein thrombosis-DVT, pulmonary embolus-PE) and to prevent them from forming again. Apixaban is an anticoagulant that works by blocking certain clotting proteins in your blood. In 2023, this provider wrote 93 Medicare prescriptions for Eliquis, about the same volume as the typical Illinois prescriber of this medication (82). Medicare paid an average of $898.87 per fill, versus $799.19 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average IL prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 141 30-Day Fills standardized to 30-day supplies 4,230 Days of Medication total across all patients in 2023 | |||
| Warfarin Sodium | 65 | $16.60 | ≈ Typical |
About Warfarin Sodium: This medication is used to treat blood clots (such as in deep vein thrombosis-DVT or pulmonary embolus-PE) and/or to prevent new clots from forming in your body. Show more ▾ Preventing harmful blood clots helps to reduce the risk of a stroke or heart attack. Conditions that increase your risk of developing blood clots include a certain type of irregular heart rhythm (atrial fibrillation), heart valve replacement, recent heart attack, and certain surgeries (such as hip/knee replacement). Warfarin is commonly called a blood thinner, but the more correct term is anticoagulant. It helps to keep blood flowing smoothly in your body by decreasing the amount of certain substances (clotting proteins) in your blood. An anticoagulant that acts by inhibiting the synthesis of vitamin K-dependent coagulation factors. Warfarin is indicated for the prophylaxis and/or treatment of venous thrombosis and its extension, pulmonary embolism, and atrial fibrillation with embolization. It is also used as an adjunct in the prophylaxis of systemic embolism after myocardial infarction. Warfarin is also used as a rodenticide. In 2023, this provider wrote 65 Medicare prescriptions for Warfarin Sodium, about 1.2 times the volume of the typical Illinois prescriber of this medication (55). Medicare paid an average of $16.60 per fill, versus $13.02 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average IL prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 109.5 30-Day Fills standardized to 30-day supplies 3,263 Days of Medication total across all patients in 2023 | |||
| Hydroxyurea | 61 | $21.60▼ below IL avg | ▲ More than typical |
About Hydroxyurea: This medication is used by people with sickle cell anemia to reduce the number of painful crises caused by the disease and to reduce the need for blood transfusions. Show more ▾ Some brands are also used to treat certain types of cancer (such as chronic myelogenous leukemia, squamous cell carcinomas). An antineoplastic agent that inhibits DNA synthesis through the inhibition of ribonucleoside diphosphate reductase. In 2023, this provider wrote 61 Medicare prescriptions for Hydroxyurea, about 1.8 times the volume of the typical Illinois prescriber of this medication (34). Medicare paid an average of $21.60 per fill, versus $34.20 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average IL prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the IL average for this medication. 89.6 30-Day Fills standardized to 30-day supplies 2,658 Days of Medication total across all patients in 2023 | |||
| Anagrelide Hcl | 45 | $206.89▼ below IL avg | ▲ More than typical |
About Anagrelide Hcl: Anagrelide is used to treat a certain blood disorder (thrombocythemia), which is caused by your bone marrow making too many platelets. Show more ▾ Platelets are a blood cell that the body uses to form blood clots. Too many platelets can cause problems with your circulation, including unwanted blood clots and bleeding problems. This drug reduces the number of platelets in the bloodstream by blocking their production. In 2023, this provider wrote 45 Medicare prescriptions for Anagrelide Hcl, about 3.2 times the volume of the typical Illinois prescriber of this medication (14). Medicare paid an average of $206.89 per fill, versus $359.83 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average IL prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the IL average for this medication. 51 30-Day Fills standardized to 30-day supplies 1,419 Days of Medication total across all patients in 2023 | |||
| XareltoRivaroxaban | 38 | $782.79▼ below IL avg | ≈ Typical |
About Xarelto: Rivaroxaban is used to prevent blood clots from forming due to a certain irregular heartbeat (atrial fibrillation) or after hip or knee replacement surgery. Show more ▾ It is also used to prevent blood clots from forming in high-risk patients with limited mobility during their hospital stay and after discharge. In addition, rivaroxaban is used to treat blood clots (such as in deep vein thrombosis-DVT or pulmonary embolus-PE) and to prevent the blood clots from forming again. Rivaroxaban may be used in children to prevent blood clots from forming after a certain heart surgery (Fontan procedure). Rivaroxaban is an anticoagulant that works by blocking certain clotting proteins in your blood. A morpholine and thiophene derivative that functions as a FACTOR XA INHIBITOR and is used in the treatment and prevention of DEEP-VEIN THROMBOSIS and PULMONARY EMBOLISM. It is also used for the prevention of STROKE and systemic embolization in patients with non-valvular ATRIAL FIBRILLATION, and for the prevention of atherothrombotic events in patients after an ACUTE CORONARY SYNDROME. In 2023, this provider wrote 38 Medicare prescriptions for Xarelto, about 83% of the volume of the typical Illinois prescriber of this medication (46). Medicare paid an average of $782.79 per fill, versus $890.91 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average IL prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the IL average for this medication. 52 30-Day Fills standardized to 30-day supplies 1,560 Days of Medication total across all patients in 2023 | |||
| ImbruvicaIbrutinib | 31 | $14,197.29▼ below IL avg | ≈ Typical |
About Imbruvica: This medication is used to treat certain cancers (such as mantle cell or marginal zone lymphoma, chronic lymphocytic leukemia/small lymphocytic lymphoma, Waldenstrom's macroglobulinemia). Show more ▾ Ibrutinib belongs to a class of drugs known as kinase inhibitors. It works by slowing or stopping the growth of cancer cells. Ibrutinib is also used to treat a certain problem that may occur after a stem cell transplant (chronic graft versus host disease). It works by weakening your body's defense system (immune system). In 2023, this provider wrote 31 Medicare prescriptions for Imbruvica, about the same volume as the typical Illinois prescriber of this medication (31). Medicare paid an average of $14,197.29 per fill, versus $15,388.97 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average IL prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the IL average for this medication. 31 30-Day Fills standardized to 30-day supplies 888 Days of Medication total across all patients in 2023 | |||
| Acyclovir | 30 | $8.15▼ below IL avg | ≈ Typical |
About Acyclovir: Acyclovir is used to treat infections caused by certain types of viruses. Show more ▾ It treats cold sores around the mouth (caused by herpes simplex), shingles (caused by herpes zoster), and chickenpox. This medication is also used to treat outbreaks of genital herpes. In people with frequent outbreaks, acyclovir is used to help reduce the number of future episodes. Acyclovir is an antiviral drug. However, it is not a cure for these infections. The viruses that cause these infections continue to live in the body even between outbreaks. Acyclovir decreases the severity and length of these outbreaks. It helps the sores heal faster, keeps new sores from forming, and decreases pain/itching. This medication may also help reduce how long pain remains after the sores heal. In addition, in people with a weakened immune system, acyclovir can decrease the risk of the virus spreading to other parts of the body and causing serious infections. A GUANOSINE analog that acts as an antimetabolite. Viruses are especially susceptible. Used especially against herpes. In 2023, this provider wrote 30 Medicare prescriptions for Acyclovir, about the same volume as the typical Illinois prescriber of this medication (28). Medicare paid an average of $8.15 per fill, versus $21.95 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average IL prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the IL average for this medication. 34 30-Day Fills standardized to 30-day supplies 990 Days of Medication total across all patients in 2023 | |||
| Nystatin | 29 | $6.80▼ below IL avg | ≈ Typical |
About Nystatin: Nystatin is used to treat fungal skin infections. Show more ▾ Nystatin is an antifungal that works by stopping the growth of fungus. Macrolide antifungal antibiotic complex produced by Streptomyces noursei, S. aureus, and other Streptomyces species. The biologically active components of the complex are nystatin A1, A2, and A3. In 2023, this provider wrote 29 Medicare prescriptions for Nystatin, about 1.2 times the volume of the typical Illinois prescriber of this medication (24). Medicare paid an average of $6.80 per fill, versus $23.50 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average IL prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the IL average for this medication. 29 30-Day Fills standardized to 30-day supplies 215 Days of Medication total across all patients in 2023 | |||
| Fluconazole | 29 | $29.70 | ▲ More than typical |
About Fluconazole: Fluconazole is used to treat vaginal yeast infections. Show more ▾ It works by stopping the growth of common types of vaginal yeast (fungus). This medication belongs to a class of drugs called azole antifungals. Triazole antifungal agent that is used to treat oropharyngeal CANDIDIASIS and cryptococcal MENINGITIS in AIDS. In 2023, this provider wrote 29 Medicare prescriptions for Fluconazole, about 1.5 times the volume of the typical Illinois prescriber of this medication (19). Medicare paid an average of $29.70 per fill, versus $14.59 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average IL prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 29 30-Day Fills standardized to 30-day supplies 817 Days of Medication total across all patients in 2023 | |||
| Anastrozole | 28 | $22.25▼ below IL avg | ▼ Less than typical |
About Anastrozole: Anastrozole is used to treat breast cancer in women after menopause. Show more ▾ Some breast cancers are made to grow faster by a natural hormone called estrogen. Anastrozole decreases the amount of estrogen the body makes and helps to slow or reverse the growth of these breast cancers. A nitrile and triazole derivative that acts as a selective nonsteroidal aromatase inhibitor. It is used in the treatment of ESTROGEN NUCLEAR RECEPTOR-positive breast cancer in postmenopausal women. In 2023, this provider wrote 28 Medicare prescriptions for Anastrozole, about a third of the volume of the typical Illinois prescriber of this medication (76). Medicare paid an average of $22.25 per fill, versus $26.77 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average IL prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the IL average for this medication. 65.5 30-Day Fills standardized to 30-day supplies 1,950 Days of Medication total across all patients in 2023 | |||
| Prednisone | 24 | $6.71 | ▼ Less than typical |
About Prednisone: Prednisone is used to treat conditions such as arthritis, blood disorders, breathing problems, severe allergies, skin diseases, cancer, eye problems, and immune system disorders. Show more ▾ Prednisone belongs to a class of drugs known as corticosteroids. It decreases your immune system's response to various diseases to reduce symptoms such as swelling and allergic-type reactions. A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver. In 2023, this provider wrote 24 Medicare prescriptions for Prednisone, about half the volume of the typical Illinois prescriber of this medication (45). Medicare paid an average of $6.71 per fill, versus $6.07 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average IL prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 24 30-Day Fills standardized to 30-day supplies 487 Days of Medication total across all patients in 2023 | |||
| Levothyroxine Sodium | 24 | $19.76 | ▼ Less than typical |
About Levothyroxine Sodium: Levothyroxine is used to treat an underactive thyroid (hypothyroidism). Show more ▾ It replaces or provides more thyroid hormone, which is normally produced by the thyroid gland. Low thyroid hormone levels can occur naturally or when the thyroid gland is injured by radiation/medications or removed by surgery. Having enough thyroid hormone is important for maintaining normal mental and physical activity. In children, having enough thyroid hormone is important for normal mental and physical development. This medication is also used to treat other types of thyroid disorders (such as thyroid cancer). This medication should not be used to treat infertility unless it is caused by low thyroid hormone levels. The major hormone derived from the thyroid gland. Thyroxine is synthesized via the iodination of tyrosines (MONOIODOTYROSINE) and the coupling of iodotyrosines (DIIODOTYROSINE) in the THYROGLOBULIN. Thyroxine is released from thyroglobulin by proteolysis and secreted into the blood. Thyroxine is peripherally deiodinated to form TRIIODOTHYRONINE which exerts a broad spectrum of stimulatory effects on cell metabolism. In 2023, this provider wrote 24 Medicare prescriptions for Levothyroxine Sodium, about 17% of the volume of the typical Illinois prescriber of this medication (145). Medicare paid an average of $19.76 per fill, versus $16.39 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average IL prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 40 30-Day Fills standardized to 30-day supplies 1,200 Days of Medication total across all patients in 2023 | |||
| Letrozole | 21 | $8.81▼ below IL avg | ▼ Less than typical |
About Letrozole: This medication is used to treat certain types of breast cancer (such as hormone-receptor-positive breast cancer) in women after menopause. Show more ▾ Letrozole is also used to help prevent the cancer from returning. Some breast cancers are made to grow faster by a natural hormone called estrogen. Letrozole decreases the amount of estrogen the body makes and helps to slow or reverse the growth of these breast cancers. A triazole and benzonitrile derivative that is a selective non-steroidal aromatase inhibitor, similar to ANASTROZOLE. It is used in the treatment of metastatic or locally advanced breast cancer in postmenopausal women. In 2023, this provider wrote 21 Medicare prescriptions for Letrozole, about a third of the volume of the typical Illinois prescriber of this medication (54). Medicare paid an average of $8.81 per fill, versus $28.69 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average IL prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the IL average for this medication. 35 30-Day Fills standardized to 30-day supplies 1,050 Days of Medication total across all patients in 2023 | |||
| Gabapentin | 21 | $10.95▼ below IL avg | ▼ Less than typical |
About Gabapentin: Gabapentin is used with other medications to prevent and control seizures. Show more ▾ It is also used to relieve nerve pain following shingles (a painful rash due to herpes zoster infection) in adults. Gabapentin is known as an anticonvulsant or antiepileptic drug. A cyclohexane-gamma-aminobutyric acid derivative that is used for the treatment of PARTIAL SEIZURES; NEURALGIA; and RESTLESS LEGS SYNDROME. In 2023, this provider wrote 21 Medicare prescriptions for Gabapentin, about a quarter of the volume of the typical Illinois prescriber of this medication (83). Medicare paid an average of $10.95 per fill, versus $21.09 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average IL prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the IL average for this medication. 27 30-Day Fills standardized to 30-day supplies 764 Days of Medication total across all patients in 2023 | |||
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 21 | $2.94▼ below IL avg | ≈ Typical |
About Sulfamethoxazole-Trimethoprim: This medication is a combination of two antibiotics: sulfamethoxazole and trimethoprim. Show more ▾ It is used to treat a wide variety of bacterial infections (such as middle ear, urine, respiratory, and intestinal infections). It is also used to prevent and treat a certain type of pneumonia (pneumocystis-type). This medication should not be used by children less than 2 months of age due to the risk of serious side effects. This medication treats only certain types of infections. It will not work for viral infections (such as flu). Unnecessary use or misuse of any antibiotic can lead to its decreased effectiveness. A drug combination with broad-spectrum antibacterial activity against both gram-positive and gram-negative organisms. It is effective in the treatment of many infections, including PNEUMOCYSTIS PNEUMONIA in AIDS. In 2023, this provider wrote 21 Medicare prescriptions for Sulfamethoxazole-Trimethoprim, about 78% of the volume of the typical Illinois prescriber of this medication (27). Medicare paid an average of $2.94 per fill, versus $5.91 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average IL prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the IL average for this medication. 26.4 30-Day Fills standardized to 30-day supplies 740 Days of Medication total across all patients in 2023 | |||
| JakafiRuxolitinib Phosphate | 19 | $14,862.14▼ below IL avg | ≈ Typical |
About Jakafi: This medication is used to treat certain bone marrow disorders (myelofibrosis, polycythemia vera). Show more ▾ It works by blocking your body from producing substances called growth factors. Growth factors cause cells to grow and divide, and cause the blood cell and spleen problems found in these disorders. Ruxolitinib belongs to a class of drugs known as kinase inhibitors. Though not a cure for these disorders, ruxolitinib may help with some of the symptoms, including abdominal discomfort, pain under left ribs, early feelings of fullness from meals, night sweats, itching, and bone/muscle pain. Ruxolitinib is also used to treat a certain problem that may occur after certain stem cell or bone marrow transplants (graft versus host disease). It works by weakening your body's defense system (immune system). In 2023, this provider wrote 19 Medicare prescriptions for Jakafi, about 76% of the volume of the typical Illinois prescriber of this medication (25). Medicare paid an average of $14,862.14 per fill, versus $15,667.22 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average IL prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the IL average for this medication. 19 30-Day Fills standardized to 30-day supplies 555 Days of Medication total across all patients in 2023 | |||
| Exemestane | 19 | $102.42▼ below IL avg | ▼ Less than typical |
About Exemestane: This medication is used to treat certain types of breast cancer (such as hormone-receptor-positive breast cancer) in women after menopause. Show more ▾ Exemestane is also used to help prevent the cancer from returning. Some breast cancers are made to grow faster by a natural hormone called estrogen. Exemestane decreases the amount of estrogen the body makes and helps to slow or reverse the growth of these breast cancers. Exemestane is usually not used in women of childbearing age. In 2023, this provider wrote 19 Medicare prescriptions for Exemestane, about 63% of the volume of the typical Illinois prescriber of this medication (30). Medicare paid an average of $102.42 per fill, versus $285.17 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average IL prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the IL average for this medication. 31 30-Day Fills standardized to 30-day supplies 930 Days of Medication total across all patients in 2023 | |||
| SprycelDasatinib | 18 | $11,516.51▼ below IL avg | ≈ Typical |
About Sprycel: This medication is used to treat certain types of cancer (chronic myeloid leukemia-CML, acute lymphoblastic leukemia-ALL). Show more ▾ It works by slowing or stopping the growth of cancer cells. A pyrimidine and thiazole derived ANTINEOPLASTIC AGENT and PROTEIN KINASE INHIBITOR of BCR-ABL KINASE. It is used in the treatment of patients with CHRONIC MYELOID LEUKEMIA who are resistant or intolerant to IMATINIB. In 2023, this provider wrote 18 Medicare prescriptions for Sprycel, about the same volume as the typical Illinois prescriber of this medication (16). Medicare paid an average of $11,516.51 per fill, versus $13,297.40 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average IL prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the IL average for this medication. 18 30-Day Fills standardized to 30-day supplies 540 Days of Medication total across all patients in 2023 | |||
| VerzenioAbemaciclib | 18 | $16,285.97 | ≈ Typical |
About Verzenio: This medication is used to treat certain types of breast cancer. Show more ▾ Abemaciclib works by slowing or stopping the growth of cancer cells. It belongs to a class of drugs known as kinase inhibitors. In 2023, this provider wrote 18 Medicare prescriptions for Verzenio, about the same volume as the typical Illinois prescriber of this medication (17). Medicare paid an average of $16,285.97 per fill, versus $14,081.31 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average IL prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 18 30-Day Fills standardized to 30-day supplies 504 Days of Medication total across all patients in 2023 | |||
| VenclextaVenetoclax | 17 | $2,419.79▼ below IL avg | ▼ Less than typical |
About Venclexta: This medication is used to treat certain types of cancer (chronic lymphocytic leukemia-CLL, small lymphocytic lymphoma-SLL, acute myeloid leukemia-AML). Show more ▾ Venetoclax is a drug that works by helping to slow or stop the growth of cancer cells. In 2023, this provider wrote 17 Medicare prescriptions for Venclexta, about 74% of the volume of the typical Illinois prescriber of this medication (23). Medicare paid an average of $2,419.79 per fill, versus $9,303.78 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average IL prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the IL average for this medication. 17 30-Day Fills standardized to 30-day supplies 448 Days of Medication total across all patients in 2023 | |||
| Dexamethasone | 15 | $22.15 | ▼ Less than typical |
About Dexamethasone: Dexamethasone is used to treat conditions such as arthritis, blood/hormone disorders, allergic reactions, skin diseases, eye problems, breathing problems, bowel disorders, cancer, and immune system disorders. Show more ▾ It is also used as a test for an adrenal gland disorder (Cushing's syndrome). Dexamethasone belongs to a class of drugs known as corticosteroids. It decreases your immune system's response to various diseases to reduce symptoms such as swelling and allergic-type reactions. An anti-inflammatory 9-fluoro-glucocorticoid. In 2023, this provider wrote 15 Medicare prescriptions for Dexamethasone, about half the volume of the typical Illinois prescriber of this medication (31). Medicare paid an average of $22.15 per fill, versus $16.03 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average IL prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 21.7 30-Day Fills standardized to 30-day supplies 454 Days of Medication total across all patients in 2023 | |||
| CalquenceAcalabrutinib Maleate | 12 | $14,592.64 | ≈ Typical |
About Calquence: This medication is used to treat certain types of cancer (such as mantle cell lymphoma, small lymphocytic lymphoma - SLL, chronic lymphocytic leukemia - CLL). Show more ▾ Acalabrutinib works by slowing or stopping the growth of cancer cells. It belongs to a class of drugs known as kinase inhibitors. In 2023, this provider wrote 12 Medicare prescriptions for Calquence, about 75% of the volume of the typical Illinois prescriber of this medication (16). Medicare paid an average of $14,592.64 per fill, versus $13,455.83 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average IL prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 12 30-Day Fills standardized to 30-day supplies 360 Days of Medication total across all patients in 2023 | |||
| Famotidine | 12 | $25.19 | ▼ Less than typical |
About Famotidine: Famotidine is used to treat ulcers of the stomach and intestines and to prevent intestinal ulcers from coming back after they have healed. Show more ▾ This medication is also used to treat certain stomach and throat (esophagus) problems (such as erosive esophagitis, gastroesophageal reflux disease-GERD, Zollinger-Ellison syndrome). It works by decreasing the amount of acid your stomach makes. It relieves symptoms such as cough that doesn't go away, stomach pain, heartburn, and difficulty swallowing. Famotidine belongs to a class of drugs known as H2 blockers. This medication is also available without a prescription. It is used to prevent and treat heartburn and other symptoms caused by too much acid in the stomach (acid indigestion). If you are taking this medication for self-treatment, it is important to read the manufacturer's package instructions carefully so you know when to consult your doctor or pharmacist. A competitive histamine H2-receptor antagonist. Its main pharmacodynamic effect is the inhibition of gastric secretion. In 2023, this provider wrote 12 Medicare prescriptions for Famotidine, about a third of the volume of the typical Illinois prescriber of this medication (34). Medicare paid an average of $25.19 per fill, versus $11.26 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average IL prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 12.2 30-Day Fills standardized to 30-day supplies 304 Days of Medication total across all patients in 2023 | |||
| Allopurinol | 11 | $8.88▼ below IL avg | ▼ Less than typical |
About Allopurinol: Allopurinol is used to treat gout and certain types of kidney stones. Show more ▾ It is also used to prevent increased uric acid levels in patients receiving cancer chemotherapy. These patients can have increased uric acid levels due to release of uric acid from the dying cancer cells. Allopurinol works by reducing the amount of uric acid made by the body. Increased uric acid levels can cause gout and kidney problems. A XANTHINE OXIDASE inhibitor that decreases URIC ACID production. It also acts as an antimetabolite on some simpler organisms. In 2023, this provider wrote 11 Medicare prescriptions for Allopurinol, about a quarter of the volume of the typical Illinois prescriber of this medication (53). Medicare paid an average of $8.88 per fill, versus $14.69 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average IL prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the IL average for this medication. 16 30-Day Fills standardized to 30-day supplies 480 Days of Medication total across all patients in 2023 | |||
About this data. The prescription history for DR. MARLON B. KLEINMAN M.D. is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2023, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Hematology & Oncology prescribing approach at this Morton Grove, IL practice.
Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average volume among IL prescribers of the same medication. Always confirm current medications and costs directly with the provider and your plan.
